Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $795.0200 (-1.68%) ($795.0200 - $795.0200) on Mon. Oct. 23, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.21% (three month average) | RSI | 48 | Latest Price | $795.0200(-1.68%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -1.2% a day on average for past five trading days. | Weekly Trend | REGN declines -0.8% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) XLV(68%) IBB(61%) DIA(59%) SDY(56%) SPLV(56%) | Factors Impacting REGN price | REGN will decline at least -0.605% in a week (0% probabilities). VXX(-53%) VIXM(-43%) TBT(-28%) USO(-16%) GLD(-14%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.605% (StdDev 1.21%) | Hourly BBV | -1.9 () | Intraday Trend | 0% | | | |
|
Resistance Level | $826.3 | 5 Day Moving Average | $814.81(-2.43%) | 10 Day Moving Average | $825.68(-3.71%) | 20 Day Moving Average | $826.3(-3.79%) | To recent high | -6% | To recent low | 9.3% | Market Cap | $84.295b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |